இந்தியாவில் மருந்து காப்புரிமை முறைப்படிதான் வழங்கப்படுகிறதா?
An article on the accessibsa project’s work in The Hindu (Tamil edition)
The Hindu (Tamil Edition) | 30 May, 2018
Weed Out Evergreen Patents
A recently published report “Pharmaceutical Patent Grants in India: How our safeguards against evergreening have failed and why the system must be reformed“, by Dr. Feroz Ali, Dr. Sudarsan Rajagopal, Dr. Venkata S. Raman and Roshan John…
Live Law | 27 May, 2018
Five Years After The Indian Supreme Court’s Novartis Verdict
On 1 April 2013, in a packed room inside India’s Supreme Court, a magnificent building in Indo-British architectural style, two judges delivered a verdict that impacted the national and global conversation about patents and patients.
Intellectual Property Watch | 20 May, 2018
The Patent Paradox In Brazil And Its Implications For Access To Medicines
The patent system was allegedly designed to allow recovery of the investment in research and development (R&D) of a new product, through the selling of the product under exclusivity for a period of time.
Intellectual Property Watch | 18 May, 2018
Groups Target EU-Mercosur FTA To Advance Access To Health In Trade Deals
AIDS activists, health activists and civil society organizations in Brazil and Argentina are pushing back against the negative effects of the planned free trade agreement between the Mercosur countries and the European Union.